Literature DB >> 3619474

Plasma thyrocalcitonin and parathyroid hormone concentrations in early neonatal hypocalcaemia.

C Romagnoli, E Zecca, G Tortorolo, A Diodato, G Fazzini, M Sorcini-Carta.   

Abstract

During the first week of life serum calcium, phosphorus, magnesium, immunoreactive thyrocalcitonin hormone, and parathyroid hormone concentrations were determined daily in 36 preterm and 29 small for gestational age, full term, healthy infants. Preterm babies with early neonatal hypocalcaemia had significantly higher concentrations of serum thyrocalcitonin hormone in the first four days of life than normocalcaemic preterm babies. Parathyroid hormone concentrations were similar in hypocalcaemic and normocalcaemic infants. In contrast, in the full term group no significant differences were detected in thyrocalcitonin hormone and parathyroid hormone patterns between hypocalcaemic and normocalcaemic subjects. This suggests two different pathogeneses for early hypocalcaemia in low birthweight infants. Hyperthyrocalcitoninaemia seems to be the main determining factor in preterm infants, while a non-hormonal pathogenesis should be considered in full term infants who are small for gestational age.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619474      PMCID: PMC1778412          DOI: 10.1136/adc.62.6.580

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  INTRAUTERINE GROWTH AS ESTIMATED FROM LIVEBORN BIRTH-WEIGHT DATA AT 24 TO 42 WEEKS OF GESTATION.

Authors:  L O LUBCHENCO; C HANSMAN; M DRESSLER; E BOYD
Journal:  Pediatrics       Date:  1963-11       Impact factor: 7.124

2.  Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.

Authors:  D B ZILVERSMIT; A K DAVIS
Journal:  J Lab Clin Med       Date:  1950-01

3.  Possible pathogenetic factors in neonatal hypocalcemia of prematurity. The role of gestation, hyperphosphatemia, hypomagnesemia, urinary calcium loss, and parathormone responsiveness.

Authors:  R C Tsang; I J Light; J M Sutherland; L I Kleinman
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

4.  Clinical assessment of gestational age in the newborn infant.

Authors:  L M Dubowitz; V Dubowitz; C Goldberg
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

Review 5.  Calcium physiology and pathology in the neonate.

Authors:  R C Tsang; E F Donovan; J J Steichen
Journal:  Pediatr Clin North Am       Date:  1976-11       Impact factor: 3.278

6.  Serum immunoreactive calcitonin in low birth weight infants. Description of early changes; effect of intravenous calcium infusion; relationships with early changes in serum calcium, phosphorus, magnesium, parathyroid hormone, and gastrin levels.

Authors:  L David; B L Salle; G Putet; D C Grafmeyer
Journal:  Pediatr Res       Date:  1981-05       Impact factor: 3.756

7.  Effect of early oral calcium supplementation on serum calcium and immunoreactive calcitonin concentration in preterm infants.

Authors:  L Sann; L David; J A Chayvialle; Y Lasne; M Bethenod
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

8.  Serial measurements of serum calcium, magnesium, parathyroid hormone, calcitonin, and 25-hydroxy-vitamin D in premature and term infants during the first week of life.

Authors:  L S Hillman; S Rojanasathit; E Slatopolsky; J G Haddad
Journal:  Pediatr Res       Date:  1977-06       Impact factor: 3.756

Review 9.  Recent advances in calcium metabolism. II. Disorders of calcium homeostasis.

Authors:  A W Root; H E Harrison
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

10.  Early oral administration of vitamin D and its metabolites in premature neonates. Effect on mineral homeostasis.

Authors:  B L Salle; L David; F H Glorieux; E Delvin; J Senterre; H Renaud
Journal:  Pediatr Res       Date:  1982-01       Impact factor: 3.756

View more
  1 in total

Review 1.  Bone disease in preterm infants.

Authors:  N Bishop
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.